4.8 Article

The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression

Journal

NATURE COMMUNICATIONS
Volume 5, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms6852

Keywords

-

Funding

  1. Fondation Coeur et Arteres [FCA R09038AA]
  2. Association pour la Recherche sur le Cancer [R13026AA-ARC-WAGNER]
  3. Fondation de France [FDFU1081-WAGNER]
  4. Ligue Nationale contre le Cancer
  5. French Government (National Research Agency, ANR) [ANR-11-LABX-0028-01]
  6. Fondation de France
  7. EMBO
  8. MRC [MC_PC_U127527180] Funding Source: UKRI
  9. Grants-in-Aid for Scientific Research [26461404] Funding Source: KAKEN
  10. Medical Research Council [MC_PC_U127527180] Funding Source: researchfish

Ask authors/readers for more resources

Angiogenesis, activation of metastasis and avoidance of immune destruction are important for cancer progression. These biological capabilities are, apart from cancer cells, mediated by different cell types, including endothelial, haematopoietic progenitor and myeloid-derived suppressor cells. We show here that all these cell types frequently express the Wilms' tumour suppressor Wt1, which transcriptionally controls expression of Pecam-1 (CD31) and c-kit (CD117). Inducible conditional knockout of Wt1 in endothelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause regression of tumour vascularization and an enhanced immune response, leading to decreased metastasis, regression of established tumours and enhanced survival. Thus, Wt1 is an important regulator of cancer growth via modulation of tumour vascularization, immune response and metastasis formation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available